Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Mar 06, 2021 3:42pm
223 Views
Post# 32736882

Medivolve is presented with great opportunity to capitalize

Medivolve is presented with great opportunity to capitalize
Medivolve is presented with a great opportunity to capitalize on its business model. All you need to do is read these lines to see what Biden GOVT wants to achieve. The collection sites model meets all of these requirements.
 
Laboratory capacity, community-based testing sites and mobile testing units, particularly in medically underserved areas. https://www.cnn.com/2021/03/04/politics/stimulus-senate-democrats-proposal/index.html
 
Medivolve already has a plan in place to install 100's covid-19 testing sites all over the USA. These cubes can be set up in any parking lot temporarily without spending a lot of money. Also, Medivolve has community-based shopping mall spaces locked up to install collection sites. All these collection sites are mobile cubes that can be moved anywhere. These cubes can be easily moved around to different underserved areas.
 
All Medivolve needs to do is hire a lobbyist to present their cubes-based model to the GOVT. Mobile collection sites meet Biden's agenda and needs. These collection sites can be set up in any community or underserved areas easily without investing a lot of money. 
 
Not saying Medivolve will do this, all I am saying is they are presented with a great opportunity to capitalize. Medivolve needs to hire some management people to quickly install more collection sites. Waiting around and making excuses, not going to work for Medivolve itself and its shareholders.
 
If management is not competent enough then invite other people to let them set up as franchise and they get a royalty.
<< Previous
Bullboard Posts
Next >>